EUROFINS SCIENT (ERFSF)
(Delayed Data from OTC)
$58.52 USD
-1.59 (-2.64%)
Updated Oct 11, 2024 02:10 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ERFSF 58.52 -1.59(-2.64%)
Will ERFSF be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ERFSF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ERFSF
All You Need to Know About EUROFINS SCIENT (ERFSF) Rating Upgrade to Buy
EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?
ERFSF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ERFSF
Eurofins Scientific price target raised by EUR 5 at Berenberg
Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2024 Update
Baron International Growth Fund Q2 2024 Shareholder Letter
Giverny Capital Asset Management Q2 2024 Letter